These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 2092151

  • 21. [Sensitivity and specificity of CEA, Ca 15-3 and MCA levels in visceral breast carcinoma metastasis].
    Delbrück H, Hagen-Aukamp C, Braun G.
    Strahlenther Onkol; 1990 Jul; 166(7):457-9. PubMed ID: 2200152
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of the BT-1 serum assay for breast cancer.
    Whitehurst MM, Aldenderfer PH, Sooy MM, Strelkauskas AJ.
    Hum Antibodies; 1999 Jul; 9(3):155-60. PubMed ID: 10690628
    [Abstract] [Full Text] [Related]

  • 23. [Protocol for the correct evaluation of CA 125 in pelvic tumescence].
    Bonelli P, Melpignano M, Piombo S, Franchini D, Condemi V.
    J Nucl Med Allied Sci; 1990 Jul; 34(4 Suppl):75-8. PubMed ID: 2092154
    [No Abstract] [Full Text] [Related]

  • 24. Tumor markers CA 125, squamous cell carcinoma antigen, and carcinoembryonic antigen in patients with adenocarcinoma of the uterine cervix.
    Duk JM, Aalders JG, Fleuren GJ, Krans M, De Bruijn HW.
    Obstet Gynecol; 1989 Apr; 73(4):661-8. PubMed ID: 2648225
    [Abstract] [Full Text] [Related]

  • 25. [Serum concentrations of the MCA tumor marker during pregnancy].
    Pütz I, Lang G, Winkler M, Rath W.
    Zentralbl Gynakol; 1996 Apr; 118(7):409-11. PubMed ID: 8766103
    [Abstract] [Full Text] [Related]

  • 26. Combination of multiple serum markers using an artificial neural network to improve specificity in discriminating malignant from benign pelvic masses.
    Zhang Z, Barnhill SD, Zhang H, Xu F, Yu Y, Jacobs I, Woolas RP, Berchuck A, Madyastha KR, Bast RC.
    Gynecol Oncol; 1999 Apr; 73(1):56-61. PubMed ID: 10094881
    [Abstract] [Full Text] [Related]

  • 27. CAM 26 and CAM 29: methodological evaluations and first clinical employment in breast cancer.
    Priolo G, Pecchio F, Rapellino M, Aimo G, Spertino F, Pepe C.
    J Nucl Med Allied Sci; 1990 Apr; 34(4 Suppl):21-3. PubMed ID: 2092121
    [No Abstract] [Full Text] [Related]

  • 28. Combined use of urinary UGP and serum CA 125 in the diagnosis of gynecological cancers.
    Plebani M, Navaglia F, Basso D, De Paoli M, Nicoletto MO, Maraglino E, Torre GC.
    Anticancer Res; 1996 Apr; 16(6B):3833-8. PubMed ID: 9042266
    [Abstract] [Full Text] [Related]

  • 29. The early detection of disseminated (metastasized) breast cancer by serial tumour marker measurements.
    Jäger W.
    Eur J Cancer Prev; 1993 Nov; 2 Suppl 3():133-9. PubMed ID: 8298443
    [No Abstract] [Full Text] [Related]

  • 30. [Value of neopterin as an oncologic laboratory parameter--observations in gynecologic tumors].
    von Broen B, Kavungu P.
    Z Gesamte Inn Med; 1990 Apr 15; 45(8):223-5. PubMed ID: 2378135
    [Abstract] [Full Text] [Related]

  • 31. Small intestinal mucin antigen (SIMA); a novel tumour marker in colorectal cancer?
    Eskelinen M, Pasanen P, Janatuinen E, Pettersson N, Linnane A, Alhava E.
    Anticancer Res; 1995 Apr 15; 15(5B):2351-6. PubMed ID: 8572651
    [Abstract] [Full Text] [Related]

  • 32. Clinical evaluation of new serum tumor markers CA M26 and CA M29 in patients with primary breast cancer.
    Eskelinen M, Tikanoja S, Brown J.
    Anticancer Res; 1990 Apr 15; 10(4):959-62. PubMed ID: 2382995
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. TATI (tumor associated trypsin inhibitor) and cancer antigen 125 (CA 125) in patients with early-stage endometrial cancer.
    Peters-Engl C, Buxbaum P, Ogris E, Sevelda P, Medl M.
    Anticancer Res; 1998 Apr 15; 18(6B):4635-9. PubMed ID: 9891532
    [Abstract] [Full Text] [Related]

  • 39. [Clinical usefulness of tumor markers in breast cancer].
    Konishi K, Karaki K, Watanabe K, Tsuda H, Konishi F.
    Rinsho Byori; 1993 Oct 15; 41(10):1108-15. PubMed ID: 8254956
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.